Concepts (152)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Intracranial Aneurysm | 12 | 2024 | 175 | 4.340 |
Why?
|
| Brain Edema | 7 | 2023 | 58 | 3.150 |
Why?
|
| Intracranial Hypertension | 5 | 2023 | 57 | 2.600 |
Why?
|
| Brain Neoplasms | 4 | 2024 | 781 | 2.280 |
Why?
|
| Intracranial Pressure | 7 | 2023 | 87 | 2.120 |
Why?
|
| Microsurgery | 3 | 2022 | 88 | 1.630 |
Why?
|
| Brain Injuries, Traumatic | 3 | 2023 | 99 | 1.570 |
Why?
|
| Glioblastoma | 2 | 2024 | 265 | 1.460 |
Why?
|
| Neurosurgery | 2 | 2022 | 99 | 1.400 |
Why?
|
| Endovascular Procedures | 6 | 2024 | 275 | 1.330 |
Why?
|
| Aerospace Medicine | 3 | 2020 | 17 | 1.250 |
Why?
|
| Military Personnel | 3 | 2020 | 91 | 1.220 |
Why?
|
| Intraoperative Neurophysiological Monitoring | 3 | 2022 | 12 | 1.210 |
Why?
|
| Aneurysm, Ruptured | 3 | 2023 | 54 | 1.210 |
Why?
|
| Embolization, Therapeutic | 4 | 2024 | 262 | 1.180 |
Why?
|
| Neurosurgical Procedures | 7 | 2024 | 232 | 1.180 |
Why?
|
| Moyamoya Disease | 2 | 2023 | 16 | 1.110 |
Why?
|
| Cerebral Revascularization | 2 | 2023 | 28 | 1.100 |
Why?
|
| Cerebrovascular Circulation | 4 | 2023 | 228 | 0.970 |
Why?
|
| Surgical Flaps | 2 | 2024 | 249 | 0.960 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2023 | 138 | 0.820 |
Why?
|
| Omentum | 1 | 2022 | 73 | 0.790 |
Why?
|
| Cerebrospinal Fluid | 1 | 2021 | 31 | 0.790 |
Why?
|
| Prostheses and Implants | 1 | 2022 | 124 | 0.770 |
Why?
|
| Skull | 2 | 2023 | 255 | 0.760 |
Why?
|
| Blood-Brain Barrier | 1 | 2021 | 74 | 0.760 |
Why?
|
| Ultrasonics | 1 | 2021 | 39 | 0.760 |
Why?
|
| Ultrasonic Therapy | 1 | 2021 | 34 | 0.750 |
Why?
|
| Neurosurgeons | 1 | 2020 | 32 | 0.730 |
Why?
|
| Compliance | 1 | 2020 | 21 | 0.730 |
Why?
|
| Glioma | 1 | 2023 | 293 | 0.720 |
Why?
|
| Motion Sickness | 1 | 2020 | 3 | 0.720 |
Why?
|
| Cardiac-Gated Imaging Techniques | 1 | 2020 | 20 | 0.720 |
Why?
|
| Habituation, Psychophysiologic | 1 | 2020 | 13 | 0.720 |
Why?
|
| Cholinergic Antagonists | 1 | 2020 | 27 | 0.710 |
Why?
|
| Brain | 5 | 2023 | 2281 | 0.710 |
Why?
|
| Hematologic Neoplasms | 1 | 2023 | 342 | 0.660 |
Why?
|
| Models, Theoretical | 1 | 2021 | 491 | 0.640 |
Why?
|
| Humans | 34 | 2024 | 89222 | 0.550 |
Why?
|
| Education, Medical, Graduate | 1 | 2020 | 393 | 0.550 |
Why?
|
| Colloid Cysts | 1 | 2016 | 2 | 0.540 |
Why?
|
| Third Ventricle | 1 | 2016 | 13 | 0.530 |
Why?
|
| Neuroendoscopy | 1 | 2016 | 18 | 0.530 |
Why?
|
| Medulloblastoma | 1 | 2016 | 37 | 0.530 |
Why?
|
| Cerebellar Neoplasms | 1 | 2016 | 37 | 0.520 |
Why?
|
| Bone and Bones | 1 | 2016 | 269 | 0.500 |
Why?
|
| Stroke | 2 | 2024 | 986 | 0.490 |
Why?
|
| Pituitary Neoplasms | 1 | 2015 | 69 | 0.480 |
Why?
|
| Magnetic Resonance Imaging | 5 | 2016 | 3444 | 0.430 |
Why?
|
| Swine | 3 | 2023 | 581 | 0.390 |
Why?
|
| Substantia Nigra | 1 | 2009 | 28 | 0.350 |
Why?
|
| Basal Ganglia | 1 | 2009 | 46 | 0.340 |
Why?
|
| Stents | 3 | 2023 | 404 | 0.330 |
Why?
|
| Retrospective Studies | 10 | 2024 | 9034 | 0.320 |
Why?
|
| Neural Pathways | 1 | 2009 | 319 | 0.300 |
Why?
|
| Middle Aged | 11 | 2024 | 25929 | 0.280 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2024 | 143 | 0.260 |
Why?
|
| Female | 15 | 2024 | 46118 | 0.260 |
Why?
|
| Evoked Potentials, Motor | 2 | 2022 | 18 | 0.260 |
Why?
|
| Aged | 10 | 2024 | 19128 | 0.250 |
Why?
|
| Off-Label Use | 1 | 2024 | 16 | 0.240 |
Why?
|
| Male | 13 | 2024 | 42347 | 0.230 |
Why?
|
| Coma | 1 | 2024 | 47 | 0.230 |
Why?
|
| Cerebral Veins | 1 | 2023 | 31 | 0.230 |
Why?
|
| Adult | 7 | 2024 | 26559 | 0.220 |
Why?
|
| Thromboembolism | 1 | 2024 | 120 | 0.220 |
Why?
|
| Aminolevulinic Acid | 1 | 2023 | 22 | 0.220 |
Why?
|
| Fluorescence | 1 | 2023 | 103 | 0.220 |
Why?
|
| Treatment Outcome | 7 | 2024 | 8227 | 0.210 |
Why?
|
| Ultrasonography | 2 | 2023 | 711 | 0.210 |
Why?
|
| Anastomosis, Surgical | 1 | 2023 | 273 | 0.200 |
Why?
|
| Machine Learning | 1 | 2024 | 257 | 0.200 |
Why?
|
| Vascular Diseases | 1 | 2022 | 118 | 0.200 |
Why?
|
| Mannitol | 1 | 2021 | 50 | 0.200 |
Why?
|
| Brain Injuries | 1 | 2023 | 164 | 0.190 |
Why?
|
| Cerebral Ventricles | 1 | 2021 | 78 | 0.190 |
Why?
|
| Meningeal Neoplasms | 1 | 2021 | 65 | 0.190 |
Why?
|
| Meningioma | 1 | 2021 | 63 | 0.190 |
Why?
|
| Citrus sinensis | 1 | 2020 | 1 | 0.190 |
Why?
|
| Ovum | 1 | 2021 | 59 | 0.190 |
Why?
|
| Endarterectomy, Carotid | 1 | 2021 | 75 | 0.190 |
Why?
|
| Transplantation, Autologous | 1 | 2022 | 343 | 0.180 |
Why?
|
| Vascular Surgical Procedures | 1 | 2022 | 149 | 0.180 |
Why?
|
| Drainage | 1 | 2021 | 162 | 0.180 |
Why?
|
| Biological Variation, Individual | 1 | 2020 | 7 | 0.180 |
Why?
|
| Encephalocele | 1 | 2020 | 26 | 0.180 |
Why?
|
| Systole | 1 | 2020 | 115 | 0.180 |
Why?
|
| Diastole | 1 | 2020 | 141 | 0.180 |
Why?
|
| Neurophysiological Monitoring | 1 | 2019 | 17 | 0.170 |
Why?
|
| Aircraft | 2 | 2018 | 26 | 0.160 |
Why?
|
| Equipment Design | 1 | 2020 | 417 | 0.160 |
Why?
|
| Young Adult | 4 | 2020 | 6301 | 0.160 |
Why?
|
| Cerebrospinal Fluid Shunts | 1 | 2019 | 53 | 0.160 |
Why?
|
| Water Loss, Insensible | 1 | 2018 | 1 | 0.160 |
Why?
|
| Dehydration | 1 | 2018 | 20 | 0.150 |
Why?
|
| Water-Electrolyte Balance | 1 | 2018 | 67 | 0.150 |
Why?
|
| Occupational Health | 1 | 2018 | 36 | 0.150 |
Why?
|
| Oxygen | 1 | 2022 | 742 | 0.140 |
Why?
|
| Follow-Up Studies | 1 | 2024 | 3661 | 0.140 |
Why?
|
| Carotid Artery, Internal | 1 | 2016 | 68 | 0.140 |
Why?
|
| Animals | 4 | 2023 | 27338 | 0.130 |
Why?
|
| Decompression, Surgical | 1 | 2016 | 87 | 0.130 |
Why?
|
| Critical Care | 1 | 2019 | 380 | 0.130 |
Why?
|
| Lumbosacral Region | 1 | 2015 | 27 | 0.130 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2022 | 1365 | 0.130 |
Why?
|
| Spinal Neoplasms | 1 | 2015 | 49 | 0.130 |
Why?
|
| Clinical Competence | 1 | 2020 | 782 | 0.120 |
Why?
|
| Biomarkers | 1 | 2021 | 1764 | 0.120 |
Why?
|
| Minimally Invasive Surgical Procedures | 1 | 2015 | 253 | 0.110 |
Why?
|
| Longitudinal Studies | 1 | 2016 | 1070 | 0.100 |
Why?
|
| Internship and Residency | 1 | 2020 | 1043 | 0.090 |
Why?
|
| Diagnosis, Differential | 1 | 2015 | 1596 | 0.090 |
Why?
|
| Magnesium Chloride | 1 | 2009 | 6 | 0.090 |
Why?
|
| Blood Pressure | 2 | 2023 | 900 | 0.080 |
Why?
|
| Child, Preschool | 1 | 2016 | 3724 | 0.080 |
Why?
|
| Adolescent | 1 | 2020 | 9247 | 0.070 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2009 | 1237 | 0.070 |
Why?
|
| Time Factors | 1 | 2016 | 5336 | 0.070 |
Why?
|
| Aged, 80 and over | 3 | 2024 | 6799 | 0.060 |
Why?
|
| Contrast Media | 1 | 2009 | 1090 | 0.060 |
Why?
|
| Anterior Cerebral Artery | 1 | 2023 | 1 | 0.060 |
Why?
|
| Propensity Score | 1 | 2024 | 147 | 0.060 |
Why?
|
| Polymethyl Methacrylate | 1 | 2023 | 13 | 0.050 |
Why?
|
| Rats | 1 | 2009 | 4041 | 0.050 |
Why?
|
| Prosthesis Design | 1 | 2024 | 298 | 0.050 |
Why?
|
| Angiography, Digital Subtraction | 1 | 2023 | 99 | 0.050 |
Why?
|
| Decision Support Techniques | 1 | 2024 | 167 | 0.050 |
Why?
|
| Evoked Potentials, Somatosensory | 1 | 2022 | 34 | 0.050 |
Why?
|
| Cerebral Angiography | 1 | 2023 | 197 | 0.050 |
Why?
|
| Blood Vessel Prosthesis | 1 | 2024 | 243 | 0.050 |
Why?
|
| Aspirin | 1 | 2023 | 159 | 0.050 |
Why?
|
| Thrombectomy | 1 | 2024 | 180 | 0.050 |
Why?
|
| Surgical Instruments | 1 | 2022 | 57 | 0.050 |
Why?
|
| Clinical Decision-Making | 1 | 2024 | 280 | 0.050 |
Why?
|
| Ergonomics | 1 | 2021 | 22 | 0.050 |
Why?
|
| Blood Vessel Prosthesis Implantation | 1 | 2024 | 227 | 0.050 |
Why?
|
| Arteries | 1 | 2022 | 180 | 0.050 |
Why?
|
| Workflow | 1 | 2021 | 80 | 0.050 |
Why?
|
| Carotid Stenosis | 1 | 2021 | 116 | 0.050 |
Why?
|
| Postoperative Complications | 2 | 2024 | 2280 | 0.040 |
Why?
|
| Specific Gravity | 1 | 2018 | 4 | 0.040 |
Why?
|
| Israel | 1 | 2018 | 57 | 0.040 |
Why?
|
| Urine | 1 | 2018 | 89 | 0.040 |
Why?
|
| Imaging, Three-Dimensional | 1 | 2021 | 596 | 0.040 |
Why?
|
| Hot Temperature | 1 | 2018 | 208 | 0.040 |
Why?
|
| Cohort Studies | 1 | 2024 | 2866 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2024 | 2301 | 0.030 |
Why?
|
| Body Weight | 1 | 2018 | 452 | 0.030 |
Why?
|
| Thoracic Vertebrae | 1 | 2015 | 51 | 0.030 |
Why?
|
| Lumbar Vertebrae | 1 | 2015 | 151 | 0.030 |
Why?
|
| Risk Factors | 1 | 2024 | 5490 | 0.030 |
Why?
|
| Prospective Studies | 1 | 2018 | 4281 | 0.020 |
Why?
|